Susmed Inc. (4263) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Susmed Inc. (4263:JPX), powered by AI.

Current Price
¥700
Market Cap
11.8B
Sector
Healthcare
What is the Susmed Inc. stock price forecast?

Susmed Inc. is currently trading at ¥700. View real-time AI analysis on Alpha Lenz.

What is Susmed Inc. insider trading activity?

View the latest insider trading data for Susmed Inc. on Alpha Lenz.

What is Susmed Inc.'s P/E ratio?

View Susmed Inc.'s valuation metrics on Alpha Lenz.

Susmed Inc.

JPX · 4263
¥700+25(+3.70%)Market closedJPX regular session 09:00–15:00 JST
Ask about Susmed Inc.'s future dividend policy...

Company Overview

Susmed Inc. is a pioneering healthcare technology company specializing in the development of digital therapeutics. Digital therapeutics involve the use of software to deliver evidence-based therapeutic interventions to patients in order to prevent, manage, or treat diseases and medical disorders. Susmed's offerings aim to enhance healthcare delivery by integrating advanced technology with traditional medical practices, thereby optimizing patient outcomes and expanding access to treatments. The company's innovations are particularly impactful in the management of chronic diseases and mental health conditions, leveraging mobile applications and wearable technology to monitor and improve patient health remotely. Its contributions are vital in industries focused on healthcare digitization, telemedicine, and personalized medicine. In the financial markets, Susmed Inc. plays a significant role as an embodiment of the increasing intersection between technology and healthcare, attracting attention from investors interested in the evolving landscape of health tech solutions. The company's focus on sustainability and efficacy in healthcare provision highlights its importance as a key player in not only the improvement of patient care but also the enhancement of healthcare systems worldwide.

CEOMr. Taro Ueno
SectorHealthcare
IndustryHealth Information Services
Employees43

Company Statistics

FY 2025

Profile

¥11,754,948,100Market Cap
N/ARevenue
0.00Shares Out
43Employees

Margins

N/AGross
N/AEBITDA
N/AOperating
N/APre-Tax
N/ANet

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

N/AROA
N/AROE
N/AROIC

Financial Health

N/ACash & Cash Equivalents
N/ANet Debt
N/ADebt/Equity
N/AInterest Cov

Frequently Asked Questions

Susmed Inc. (ticker: 4263) is a company listed on JPX in the Healthcare sector (Health Information Services). It has approximately 43 employees. Market cap is $11.8B.

The current price is 700 with a P/E ratio of -x and P/B of -x.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Susmed Inc. (4263) Stock Forecast 2026 ¥700 — Price, Financials & Analyst Targets | Alpha Lenz